v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]    
Revenues $ 13,175,000 $ 16,125,000
Cost of sales 9,410,000 10,907,000
Gross profit 3,765,000 5,218,000
Operating expenses:    
Selling and administrative 4,906,000 5,115,000
Research and development 1,037,000 1,315,000
Total operating expenses 5,943,000 6,430,000
Operating loss (2,178,000) (1,212,000)
Interest income (expense), net (384,000) (457,000)
Net loss $ (2,562,000) $ (1,669,000)
Net loss per share - basic $ (0.15) $ (0.10)
Net loss per share - diluted $ (0.15) $ (0.10)
Weighted average number of common shares outstanding - basic 16,835,698 16,682,465
Weighted average number of common shares outstanding - diluted 16,835,698 16,682,465

Source